Correlation Between SentinelOne and Aarti Drugs
Specify exactly 2 symbols:
By analyzing existing cross correlation between SentinelOne and Aarti Drugs Limited, you can compare the effects of market volatilities on SentinelOne and Aarti Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SentinelOne with a short position of Aarti Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of SentinelOne and Aarti Drugs.
Diversification Opportunities for SentinelOne and Aarti Drugs
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between SentinelOne and Aarti is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding SentinelOne and Aarti Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarti Drugs Limited and SentinelOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SentinelOne are associated (or correlated) with Aarti Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarti Drugs Limited has no effect on the direction of SentinelOne i.e., SentinelOne and Aarti Drugs go up and down completely randomly.
Pair Corralation between SentinelOne and Aarti Drugs
Taking into account the 90-day investment horizon SentinelOne is expected to generate 1.64 times more return on investment than Aarti Drugs. However, SentinelOne is 1.64 times more volatile than Aarti Drugs Limited. It trades about 0.04 of its potential returns per unit of risk. Aarti Drugs Limited is currently generating about 0.0 per unit of risk. If you would invest 1,642 in SentinelOne on November 27, 2024 and sell it today you would earn a total of 546.00 from holding SentinelOne or generate 33.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.51% |
| Values | Daily Returns |
SentinelOne vs. Aarti Drugs Limited
Performance |
| Timeline |
| SentinelOne |
| Aarti Drugs Limited |
SentinelOne and Aarti Drugs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SentinelOne and Aarti Drugs
The main advantage of trading using opposite SentinelOne and Aarti Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SentinelOne position performs unexpectedly, Aarti Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will offset losses from the drop in Aarti Drugs' long position.| SentinelOne vs. Crowdstrike Holdings | SentinelOne vs. Okta Inc | SentinelOne vs. Cloudflare | SentinelOne vs. MongoDB |
| Aarti Drugs vs. Coffee Day Enterprises | Aarti Drugs vs. Sonata Software Limited | Aarti Drugs vs. Speciality Restaurants Limited | Aarti Drugs vs. Transport of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |